GTC Biotherapeutics (fka GTCB)

[croumagnon]

"I can guarantee that something will happen to resolve the situation -- at a minimum -- to allow them to get through February and potential US approval of ATRYN."

The good thing about GTCB in this turbulent market is that we know the pps will not drop much from these levels. At a market cap of $30 Million, worse case scenario it would be a drop in the bucket for LEO or Ovation to buy the company outright at these levels. Personally, I think GTCB is currently easily worth $100 million but at least we know that we have a floor at about where we currently are. This can not be said with respect to the market as a whole because I expect more downside ahead as the economy slumps into the recession, so GTCB is not a bad place to park one's cash currently..